{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:10:20Z","timestamp":1794021020623,"version":"4.8.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,2,5]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Loss of DGK\u03b5 in endothelial cells induces cell death, impairs angiogenic responses, and leads to an activated and prothrombotic phenotype. DGKE silencing in resting endothelial cells does not affect complement activation at their surface.<\/jats:p>","DOI":"10.1182\/blood-2014-06-579953","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T23:10:07Z","timestamp":1418253007000},"page":"1038-1046","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":76,"title":["Loss of DGK\u03b5 induces endothelial cell activation and death independently of complement activation"],"prefix":"10.1182","volume":"125","author":[{"given":"Sarah","family":"Bruneau","sequence":"first","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1064, Institut de Transplantation Urologie-Nephrologie, Centre Hospitalier Universitaire de Nantes, University of Nantes, Nantes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"N\u00e9el","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1064, Institut de Transplantation Urologie-Nephrologie, Centre Hospitalier Universitaire de Nantes, University of Nantes, Nantes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubka T.","family":"Roumenina","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1138, Cordeliers Research Center, Complement and Diseases Team, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes Sorbonne Paris-Cit\u00e9, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie (Paris-6), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Frimat","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1138, Cordeliers Research Center, Complement and Diseases Team, Paris, France;"},{"name":"Service de N\u00e9phrologie, H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire de Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e6titia","family":"Laurent","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1064, Institut de Transplantation Urologie-Nephrologie, Centre Hospitalier Universitaire de Nantes, University of Nantes, Nantes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1138, Cordeliers Research Center, Complement and Diseases Team, Paris, France;"},{"name":"Assistance Publique\u2014H\u00f4pitaux de Paris, Service d\u2019Immunologie Biologique, H\u00f4pital Europ\u00e9en Georges Pompidou, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Fakhouri","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche S-1064, Institut de Transplantation Urologie-Nephrologie, Centre Hospitalier Universitaire de Nantes, University of Nantes, Nantes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111818351180900_B1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome.","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2019111818351180900_B2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2019111818351180900_B3","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","article-title":"Genetics and complement in atypical HUS.","volume":"25","author":"Kavanagh","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2019111818351180900_B4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2010.08295.x","article-title":"Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.","volume":"150","author":"S\u00e1nchez-Corral","year":"2010","journal-title":"Br J Haematol"},{"issue":"1-2","key":"2019111818351180900_B5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS.","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"issue":"4","key":"2019111818351180900_B6","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome.","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"issue":"22","key":"2019111818351180900_B7","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019111818351180900_B8","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"issue":"4","key":"2019111818351180900_B9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome.","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"issue":"13","key":"2019111818351180900_B10","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111818351180900_B11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111818351180900_B12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2019111818351180900_B13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2019111818351180900_B14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejim.2013.05.008","article-title":"Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.","volume":"24","author":"Fakhouri","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"11","key":"2019111818351180900_B15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2019111818351180900_B16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"2019111818351180900_B17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1681\/ASN.2013080886","article-title":"Phenotypic expansion of DGKE-associated diseases.","volume":"25","author":"Westland","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2019111818351180900_B18","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1021\/cr1004106","article-title":"Regulation and functions of diacylglycerol kinases.","volume":"111","author":"Shulga","year":"2011","journal-title":"Chem Rev"},{"issue":"24","key":"2019111818351180900_B19","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.febslet.2011.11.016","article-title":"Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle.","volume":"585","author":"Shulga","year":"2011","journal-title":"FEBS Lett"},{"key":"2019111818351180900_B20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0076-6879(07)34016-0","article-title":"Measurement of mammalian diacylglycerol kinase activity in vitro and in cells.","volume":"434","author":"Epand","year":"2007","journal-title":"Methods Enzymol"},{"issue":"3","key":"2019111818351180900_B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN.","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"28","key":"2019111818351180900_B22","doi-asserted-by":"crossref","first-page":"17354","DOI":"10.1074\/jbc.272.28.17354","article-title":"Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells.","volume":"272","author":"Pettitt","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111818351180900_B23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1043-2760(99)00232-5","article-title":"Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor.","volume":"11","author":"Naor","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2019111818351180900_B24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2622","article-title":"DGKE and atypical HUS.","volume":"45","author":"Quaggin","year":"2013","journal-title":"Nat Genet"},{"issue":"13","key":"2019111818351180900_B25","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V96.13.4216","article-title":"Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.","volume":"96","author":"Verheul","year":"2000","journal-title":"Blood"},{"key":"2019111818351180900_B26","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.2741\/3122","article-title":"MSK activation and physiological roles.","volume":"13","author":"Arthur","year":"2008","journal-title":"Front Biosci"},{"issue":"1","key":"2019111818351180900_B27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570161052773898","article-title":"Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases.","volume":"3","author":"Ku\u0142do","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"2019111818351180900_B28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"issue":"18","key":"2019111818351180900_B29","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","article-title":"A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111818351180900_B30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccr.2005.12.021","article-title":"ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis.","volume":"9","author":"Mavria","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111818351180900_B31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.200103096","article-title":"p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis.","volume":"156","author":"Matsumoto","year":"2002","journal-title":"J Cell Biol"},{"issue":"13","key":"2019111818351180900_B32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace.","volume":"113","author":"F\u00f6rstermann","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"2019111818351180900_B33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood.V75.3.688.688","article-title":"Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells.","volume":"75","author":"Paleolog","year":"1990","journal-title":"Blood"},{"issue":"1","key":"2019111818351180900_B34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.V91.1.118","article-title":"Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis.","volume":"91","author":"Vischer","year":"1998","journal-title":"Blood"},{"issue":"11","key":"2019111818351180900_B35","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/j.1538-7836.2008.03138.x","article-title":"Protein kinase C-delta mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine.","volume":"6","author":"Lorenzi","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"Pt 2","key":"2019111818351180900_B36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/bj2860631","article-title":"The roles of protein kinase C and intracellular Ca2+ in the secretion of von Willebrand factor from human vascular endothelial cells.","volume":"286","author":"Carew","year":"1992","journal-title":"Biochem J"},{"issue":"9","key":"2019111818351180900_B37","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2215\/CJN.01640214","article-title":"Complement mutations in diacylglycerol kinase-\u03b5-associated atypical hemolytic uremic syndrome.","volume":"9","author":"S\u00e1nchez Chinchilla","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"2019111818351180900_B38","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2012111064","article-title":"Cyclosporine induces endothelial cell release of complement-activating microparticles.","volume":"24","author":"Renner","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"22","key":"2019111818351180900_B39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111818351180900_B40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy.","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111818351180900_B41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/6\/1038\/1387003\/1038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/6\/1038\/1387003\/1038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T18:35:29Z","timestamp":1574102129000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/125\/6\/1038\/34073\/Loss-of-DGK%CE%B5-induces-endothelial-cell-activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,2,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-06-579953","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725276451.793502628","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}